Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Upper respiratory tract infections.

D A Moore1, M Sharland, J S Friedland

  • 1Department of Infectious Diseases, Hammersmith Hospital, London, UK.

Current Opinion in Pulmonary Medicine
|May 6, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical standards for antimicrobial stewardship in TB care.

IJTLD open·2025
Same author

Associations between mental illness, TB risk and migrant status.

IJTLD open·2024
Same author

Predicting histopathological features of aggressiveness in lung cancer using CT radiomics: a systematic review.

Clinical radiology·2024
Same author

Cefotaxime/sulbactam plus gentamicin as a potential carbapenem- and amikacin-sparing first-line combination for neonatal sepsis in high ESBL prevalence settings.

The Journal of antimicrobial chemotherapy·2023
Same author

Transcriptional changes detected in fecal RNA from neonatal dairy calves of different breeds following gastrointestinal disease of varying severity.

PloS one·2022
Same author

Clinical standards for the diagnosis, treatment and prevention of TB infection.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

This review covers advances in respiratory syncytial virus (RSV) and influenza treatments, meningococcal chemoprophylaxis, and sore throat management. Evidence supports specific immunoglobulin and monoclonal antibodies for RSV, while neuraminidase inhibitors are established for influenza.

Area of Science:

  • Infectious Diseases
  • Virology
  • Public Health

Background:

  • Upper respiratory tract infections (URTIs) remain a significant public health concern.
  • Advances in antiviral therapies and prophylactic measures are crucial for managing URTIs.
  • Understanding pathogen-specific treatments and public health implications is essential.

Purpose of the Study:

  • To review recent advancements in the management of key upper respiratory tract infections.
  • To highlight current evidence and controversies in URTI treatment strategies.
  • To inform clinical practice and public health approaches to URTIs.

Main Methods:

  • Literature review of recent studies on respiratory syncytial virus (RSV), influenza, and meningococcal infections.
  • Analysis of treatment efficacy for specific URTIs, including antiviral agents and antibiotics.

Related Experiment Videos

  • Evaluation of prophylactic strategies and management guidelines for sore throat.

    • Main Results:

    • Ribavirin use for RSV is limited; immunoglobulin prophylaxis and monoclonal antibodies show promise.
    • Neuraminidase inhibitors are effective for influenza, but concerns exist regarding early use and resource allocation.
    • Avian influenza (H5N1) outbreak provided insights into pathogenesis with minimal human-to-human spread.
    • Ciprofloxacin is favored over rifampicin for meningococcal chemoprophylaxis, with excellent efficacy in eradicating carriage.
    • Evidence for antibiotic therapy in adult sore throat is lacking; shorter courses may be effective in children.

    Conclusions:

    • Current strategies for RSV and influenza management are evolving, with new therapeutic options emerging.
    • Effective chemoprophylaxis exists for meningococcal disease, and antibiotic use for sore throat requires careful consideration.
    • Continued research and evidence-based guidelines are necessary for optimal URTI management.